Brentuximab Vedotin for Newly Diagnosed CHL in Chinese CAYA Based on PET/CT Assessment

1.8mg/kg/dose (MAX 180 mg)

For patients who did not achieve complete metabolic response at early response assessment based on PET/CT result.

25mg/m2/dose,

125 mg/m2/dose

20 mg/m2, BID, orally

600 mg/m2/dose

250 mg/m2/dose; For patients in intermediate/high risk group who did not achieve complete metabolic response at early assessment based on PET/CT results.

3mg/kg/dose; For patients in intermediate/high risk group who did not achieve complete metabolic response at late assessment based on PET/CT results.

180mg/m2/dose; For patients in intermediate/high risk group who did not achieve complete metabolic response at late assessment based on PET/CT results.